Synthesis of human molecules by foreign organisms for pharmaceutical purposes
- Artificial manufacture of human hormones
Incidence
The insertion of insulin-producing genes into bacteria enabled cheaper, large-scale production of insulin hormone.
A 2019 report valued the market in therapeutics, mostly arising through recombinant genetic technologies, at more than US$315 billion.
Claim
The biggest fear about genetic engineering of medicaments is that it would be used for social purposes and not medical purposes.
Broader
Narrower
Aggravates
Aggravated by
Reduces
Related
Value
SDG
Metadata
Database
World problems
Type
(E) Emanations of other problems
Biological classification
N/A
Subject
- Biosciences » Biochemicals
- Biosciences » Biology
- Fundamental sciences » Chemicals
- Health care » Pharmacy
- Industry » Manufacture
- Mankind » Human
- Society » Foreign
Content quality
Unpresentable
Language
English
1A4N
J0533
DOCID
12005330
D7NID
149478
Editing link
Official link
Last update
Nov 18, 2022